TP53 mutations were suggested to affect global DNAm through DNMT1 overexpression in lung cancer, and increased genomic instability, but how this is linked to the changes observed, largely of hypomethylation, is unclear. The gene discussed is DNMT1; the disease is lung carcinoma.